Back to results
US 12,059,455 B2Granted
Systems and methods for preparing a thrombin serum
AssigneeArthrex, Inc.
InventorsChristopher Bare, Abigail Nabors, Melissa Tucker, Robert Harrison
Life of this patent
Estimating the term…
Abstract
A system for preparing a thrombin serum that can include a containment device, a cage received within the containment device, a cap attachable to the containment device, an inlet port configured to introduce a non-anti-coagulated autologous blood fluid into the containment device, and an outlet port. An activator, such as glass beads, can be present within the containment device.
Claims25
A method for preparing a clotted blood product, comprising:
- (i) incubating a first autologous blood fluid in a containment device, wherein the containment device comprises:
- (a) a longitudinal axis;
- (b) a cage received within said containment device, the cage having a wall or walls that extend along a longitudinal axis into the containment device, wherein the cage wall or walls include a plurality of openings;
- (c) a cap attached to said containment device;
- (d) an inlet port configured to introduce the first autologous blood fluid into said containment device, wherein the inlet port is located radially outwardly of the cage relative to the longitudinal axis, such that a fluid is delivered to the containment device between an inner wall of the containment device and an outer wall of the cage;
- (e) an outlet port configured to remove a thrombin serum from said containment device;
- and
- (f) a plurality of beads within the containment device;
- (ii) shaking or inverting the containment device;
- (iii) extracting a thrombin serum from the containment device;
- (iv) adding the thrombin serum to a second autologous blood fluid to produce a clotted product;
- and
- (v) collecting the clotted product.
10 more elements
A method for preparing a thrombin serum, comprising:
- (i) incubating a first amount of a non-anticoagulated autologous blood fluid in a containment device, wherein the containment device comprises:
- (a) a longitudinal axis;
- (b) a cage received within said containment device, the cage having a wall or walls that extend along a longitudinal axis into the containment device, wherein the cage wall or walls include a plurality of openings;
- (c) a cap attached to said containment device;
- (d) an inlet port configured to introduce the non-anti-coagulated autologous blood fluid into said containment device, wherein the inlet port is located radially outwardly of the cage relative to the longitudinal axis, such that a fluid is delivered to the containment device between an inner wall of the containment device and an outer wall of the cage;
- (e) an outlet port configured to remove a thrombin serum from said containment device;
- and
- (f) a plurality of beads within the containment device;
- (ii) shaking or inverting the containment device;
- and
- (iii) extracting a thrombin serum from the containment device.
8 more elements
Dependencies are inferred from the claim text.